Search

Your search keyword '"Laitman Y"' showing total 327 results

Search Constraints

Start Over You searched for: Author "Laitman Y" Remove constraint Author: "Laitman Y"
327 results on '"Laitman Y"'

Search Results

1. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

2. Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review

3. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

5. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

6. Erratum: Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature communications (2021) 12 1 (1078)).

7. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants.

8. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

9. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (vol 12, 1078, 2021)

10. Common Susceptibility Loci for Male Breast Cancer

11. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

12. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

16. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

17. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

18. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

19. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

20. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

21. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

22. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status

24. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

25. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

26. The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

27. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers

28. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

29. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

30. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

31. Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148

33. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

34. Prolonged overall survival of metastatic gastric cancer patients with BRCA germline mutations

35. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

36. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

37. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

38. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

39. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

40. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

41. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

42. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma†

43. Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

44. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

45. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

46. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

47. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

48. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3

49. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

50. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Catalog

Books, media, physical & digital resources